Back to results
US 11,998,579 B2Granted
Immunogenic composition
AssigneeGlaxosmithkline Biologicals SA
InventorsChristiane Marie-Paule Simone Jeanne Feron, Sandra Giannini
Life of this patent
Estimating the term…
Abstract
The present invention discloses a recombinant bacteriophage comprising a phage genome polynucleotide including a gene encoding a heterologous antigen protein(s) and a killing gene encoding a protein that is capable of killing a host bacterium. Such a recombinant bacteriophage is designed to prime a subject's immune response and to kill the bacterium that it infects such that the “prime and kill” bacteriophage provides two lines of protection against infectious disease.
Claims6
A recombinant bacteriophage comprising
- a phage genome polynucleotide including a deletion of at least one gene encoding a bacteriophage structural protein;
- a gene encoding a heterologous antigen protein(s) without an appropriate leader sequence, wherein the expression of the heterologous antigen protein is driven by a strong promoter, and
- a killing gene encoding a protein that kills a host bacterium, wherein the expression of the killer gene is driven by a weak promoter,
- wherein the recombinant bacteriophage is incapable of carrying out a lysogenic cycle by deletion of a portion of the phage genome polynucleotide that encodes an enzyme required for the lysogenic cycle,
- wherein the recombinant bacteriophage is adapted to bind to a host bacterium and insert the phage genome polynucleotide into said host bacterium;
- wherein following entry of the recombinant bacteriophage into a host bacterium, expression of the heterologous antigen protein is driven by the strong promoter,
- wherein the heterologous antigen is released from the host bacterium and the heterologous antigen protein(s) is not expressed as part of a phage coat/capsid protein;
- wherein the heterologous antigen protein, after expression is released into the cytoplasm of a bacterium infected by the bacteriophage due to the absence of the appropriate leader sequence.
5 more elements
Dependencies are inferred from the claim text.